Anti-YME1L1 monoclonal antibody

Pre-made anti-YME1L1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to YME1L1/YME1L1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2292-Ab-1/ GM-Tg-hg-IP2292-Ab-2Anti-Human YME1L1 monoclonal antibodyHuman
GM-Tg-rg-IP2292-Ab-1/ GM-Tg-rg-IP2292-Ab-2Anti-Rat YME1L1 monoclonal antibodyRat
GM-Tg-mg-IP2292-Ab-1/ GM-Tg-mg-IP2292-Ab-2Anti-Mouse YME1L1 monoclonal antibodyMouse
GM-Tg-cynog-IP2292-Ab-1/ GM-Tg-cynog-IP2292-Ab-2Anti-Cynomolgus/ Rhesus macaque YME1L1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2292-Ab-1/ GM-Tg-felg-IP2292-Ab-2Anti-Feline YME1L1 monoclonal antibodyFeline
GM-Tg-cang-IP2292-Ab-1/ GM-Tg-cang-IP2292-Ab-2Anti-Canine YME1L1 monoclonal antibodyCanine
GM-Tg-bovg-IP2292-Ab-1/ GM-Tg-bovg-IP2292-Ab-2Anti-Bovine YME1L1 monoclonal antibodyBovine
GM-Tg-equg-IP2292-Ab-1/ GM-Tg-equg-IP2292-Ab-2Anti-Equine YME1L1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2292-Ab-1/ GM-Tg-hg-IP2292-Ab-2; GM-Tg-rg-IP2292-Ab-1/ GM-Tg-rg-IP2292-Ab-2;
GM-Tg-mg-IP2292-Ab-1/ GM-Tg-mg-IP2292-Ab-2; GM-Tg-cynog-IP2292-Ab-1/ GM-Tg-cynog-IP2292-Ab-2;
GM-Tg-felg-IP2292-Ab-1/ GM-Tg-felg-IP2292-Ab-2; GM-Tg-cang-IP2292-Ab-1/ GM-Tg-cang-IP2292-Ab-2;
GM-Tg-bovg-IP2292-Ab-1/ GM-Tg-bovg-IP2292-Ab-2; GM-Tg-equg-IP2292-Ab-1/ GM-Tg-equg-IP2292-Ab-2
Products NameAnti-YME1L1 monoclonal antibody
Formatmab
Target NameYME1L1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-YME1L1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2292-Ag-1Recombinant multi-species YMEL1/ YME1L1/ FTSH protein


    Target information

    Target IDGM-IP2292
    Target NameYME1L1
    Gene ID10730,27377,114217,714687,477988,101084035,505118,100065311
    Gene Symbol and SynonymsFTSH,FtsH1,MEG4,OPA11,PAMP,YME1L,YME1L1
    Uniprot AccessionQ96TA2,Q925S8
    Uniprot Entry NameYMEL1_HUMAN,YMEL1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136758
    Target ClassificationN/A

    The target: YME1L1, gene name: YME1L1, also named as FTSH, MEG4, OPA11, PAMP, YME1L. The protein encoded by this gene is the human ortholog of yeast mitochondrial AAA metalloprotease, Yme1p. It is localized in the mitochondria and can functionally complement a yme1 disruptant yeast strain. It is proposed that this gene plays a role in mitochondrial protein metabolism and could be involved in mitochondrial pathologies. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.